BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition
2011 · Nature · 200 citations
https://doi.org/10.1038/nature09883
Y
Yong‐Mi Kim
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
336
Papers
8.2K
Citations
49
h-index
108
i10-index
Yong‐Mi Kim is an academic researcher from University of Southern California. The author has contributed to research in topics: Acute Lymphoblastic Leukemia research & Chronic Myeloid Leukemia Treatments & CAR-T cell therapy research. The author has an h-index of 49, co-authored 286 publications.
ORCID: 0000-0003-3793-6438Papers by this author
worksCAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression
2020 · Leukemia · 181 citations
https://doi.org/10.1038/s41375-020-0792-2
Outcomes after radical hysterectomy in patients with early-stage adenocarcinoma of uterine cervix
2010 · British Journal of Cancer · 104 citations
https://doi.org/10.1038/sj.bjc.6605705
Effects of the small-molecule inhibitor of integrin α4, TBC3486, on pre-B-ALL cells
2014 · Leukemia · 34 citations
https://doi.org/10.1038/leu.2014.182
Bioluminescence imaging of leukemia cell lines in vitro and in mouse xenografts: effects of monoclonal and polyclonal cell populations on intensity and kinetics of photon emission
2013 · Journal of Hematology & Oncology · 28 citations
https://doi.org/10.1186/1756-8722-6-10
A Deeply Quiescent Subset of CML LSC depend on FAO yet Avoid DeleteriousROS by Suppressing Mitochondrial Complex I
2023 · Current Molecular Pharmacology · 14 citations
https://doi.org/10.2174/1874467217666230906092236
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat